Wordt geladen...
Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study
BACKGROUND: Several studies have shown that heart rate control with selective beta-1 blockers in septic shock is safe. In these trials, esmolol was administered 24 h after onset of septic shock in patients who remained tachycardic. While an earlier use of beta-blockers might be beneficial, such use...
Bewaard in:
| Gepubliceerd in: | Crit Care |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7791811/ https://ncbi.nlm.nih.gov/pubmed/33413583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-03445-w |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|